Abstract
Objective: Objective: To evaluate the potential of SCGB2A1, a top differentially expressed gene in various histological types of epithelial ovarian carcinomas, as a novel tumor antigen for ovarian cancer immunotherapy.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
